Conference Speakers
The conference featured a Keynote Speaker:
- Dr. Peter Greer, from the Cancer Biology and Genetics Division of Queen’s Cancer Research Institute in Kingston, Ontario. The title of his seminar was “Arpin: A novel regulator of actin branching and a potential anti-metastasis therapeutic target”.
Additional presentations were made by local investigators, including Dr. S. Widenmaier (Research Fellow, Physiology), Dr. E. Dadachova (Pharmacy & Nutrition), Dr. K. Bonham (SCA, Research), Dr. L. Chelico (Microbiology & Immunology), Dr. F. Cayabyab (Surgery), Dr. S. Papagerakis (Surgery), Dr. I. Badea (Pharmacy & Nutrition), Dr. R. Singh (PDF, Biochemistry) and Dr. F. Islam (Graduate Student, Cancer Cluster).
Poster Presentation Winners
The conference also included poster presentations, and recognized several poster winners:
Graduate Student, First Place ($300):
Omar Abuhussein (Supervisor: Dr. F. Vizeacoumar, Cancer Cluster)
Sphingosine kinase 2 as a potential therapeutic target in telomerase overexpressing cancers
Graduate Student, Second Place ($200):
Chelsea Cunningham (Supervisor: Dr. F. Vizeacoumar, Cancer Cluster)
Exploiting the synthetic dosage lethal interactions of polo-like kinase 1 for targeted cancer therapeutics
Graduate Student, Third Place ($100):
Samitha Andrahennadi (Supervisor: Dr. Uppalapati, Dept of Pathology)
Developing small protein inhibitors to exploit a synthetic dosage lethal interaction in an adhesion g protein-coupled receptor
Post-Doctoral Fellow ($200):
Dr. Arun Kumar Annan Sudarsan (Supervisor: Dr. F. Vizeacoumar and Dr. Uppalapati, Cancer Cluster)
Developing small-protein based affinity reagents for breast cancer cell surface receptors
The success of the conference was in large part due to excellent job of organizers: Drs. Keith Bonham, Franco Vizeacoumar and Erique Lukong. Invaluable assistance was provided by Sheila Ash and Lori Amson, as well as Frederick Vizeacoumar (website/technical) and Mark Boyd (logistics). This conference was supported by funds from the Saskatchewan Cancer Agency, the Saskatchewan Health Research Foundation and ThermoFisher Scientific.